1.
Manag Care
; 26(3): 36-37, 2017 03.
Article
in English
| MEDLINE
| ID: mdl-28510525
ABSTRACT
Constipation can be a serious and painful problem, and we shouldn't dismiss other people's suffering. On the other hand there's a danger when new medications are compared against placebo rather than against over-the-counter products with a history of effectiveness.
Subject(s)
Constipation/drug therapy , Drug Prescriptions/economics , Gastrointestinal Agents/economics , Gastrointestinal Agents/therapeutic use , Laxatives/economics , Laxatives/therapeutic use , Natriuretic Peptides/economics , Natriuretic Peptides/therapeutic use , Nonprescription Drugs/economics , Nonprescription Drugs/therapeutic use , Chloride Channel Agonists/economics , Chloride Channel Agonists/therapeutic use , Chronic Disease , Clinical Trials as Topic , Drug Costs , Guanylyl Cyclase C Agonists/economics , Guanylyl Cyclase C Agonists/therapeutic use , Humans , Lubiprostone/economics , Lubiprostone/therapeutic use , Peptides/economics , Peptides/therapeutic use
2.
G Ital Cardiol (Rome)
; 17(1): 48-50, 2016 Jan.
Article
in Italian
| MEDLINE
| ID: mdl-26901258